Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Platter who wrote (5470)	9/4/1998 12:02:00 PM
From: Tokyo VD	Respond to of 7041

Platter, I'll try this one more time. Market makers don't need to borrow shares to "short" stocks. BRL (Zeneca) was in front of an FDA review panel on Sept. 2nd. Everyone and their brother knows that the panel must make a decision. Therefore, to suggest that people were caught by surprise when a meeting had been scheduled for months is ABSURD. Now, Zonagen has said that it is anticipating a decision by the FDA in approximately 10 months. So, what the heck are you trying to say that the company, the FDA, and the rest of the world are unaware that the this review process is still almost a year from completion? Tokyo

To: Platter who wrote (5470)	9/4/1998 12:03:00 PM
From: Bill Wexler	Respond to of 7041

Of course BRL actually has sales and earnings, and trades at a P/E of about 23. The Zonagen fraud has no real sales and has been a money loser since founding. I notice that the song of the shills is now: "Watch out shorty, the short interest is so high that the stock is going to skyrocket soon." Actually, stocks with heavy short interest tend to underperform the market over the long run. The reason a stock gets heavily shorted in the first place is because there are fundamental problems with the company. In Zonagen's case, short sellers understand that Zonagen is nothing more than a fraudulent stock promotion scheme run by a thief. Vasomax will not be approved for the very simple reason that there is zero scientific evidence that oral phentolamine is safe and effective.

To: Platter who wrote (5470)	9/4/1998 12:14:00 PM
From: Dauntless	Read Replies (1) \| Respond to of 7041

Platter - I'm long but.. In this instance I think you may have some bogus information. As much as I'd like a decision now, the FDA's published response time for NDA's is somewhere just under 12 months. That puts decision about 10 months from now - given "normal" conditions. I agree with the rest of your post, however, as a newcomer to this thread you have to be aware that facts don't always matter. Someone suggested that the recent volume is not unusually low. Check the bottom of this screen & it clearly says the average trading volume is 267,000 shares/day. Click on "Chart" & check the recent trading volumes. As to the recent downward trend - don't mistake a bear market for intelligence.

To: Platter who wrote (5470)	9/4/1998 2:27:00 PM
From: VLAD	Respond to of 7041

Platter, SEC rules allow market makers to short stock that they do not own or need to borrow. The only stipulations are that the money is in the position and the shares that were shorted but not owned nor borrowed are covered within 10 trading days. In essence this is why NASDAQ stocks are so manipulated. The market maker can cover in 10 days but then just reshort new positions right after covering. IMO the NASDAQ market is a big scam which allows the market makers carte blanche to do as they please.